Adjunctive Methylphenidate ER in Patients With Schizophrenia to Improve Functional and Cognitive Outcomes

PHASE2RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 9, 2022

Primary Completion Date

September 9, 2025

Study Completion Date

September 9, 2025

Conditions
Schizophrenia Schizoaffective
Interventions
DRUG

Apo-Methylphenidate ER

For inpatients, the study medication will be administered by unit nurses, alongside their other medications. For outpatients, the study medication will be dispensed to the participant by the research assistant during their weekly visit. Patients will continue their regular medications as per standard of care.

Trial Locations (1)

K1Z 7K4

RECRUITING

Royal Ottawa Mental Health Centre, Ottawa

All Listed Sponsors
lead

The Royal Ottawa Mental Health Centre

OTHER